Hongene Biotech announces grant to expand global access to mRNA vaccine raw materials
Hongene Biotech announced the receipt of a grant from the Gates Foundation to develop high-quality, affordable, and patent-free…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
mRNA vaccine
Sanofi’s mRNA vaccine candidate for prevention of chlamydia infection gains USFDA fast track…
Sanofi is planning a phase 1/2 randomised, clinical study designed to evaluate the immunogenicity and safety of the chlamydia…
MoS S&T launches GEMCOVAC-OM
India’s first mRNA vaccine developed using the indigenous platform technology by Gennova, with funding support from DBT &…
China approves its first mRNA vaccine from CSPC
The company said its independently developed mRNA vaccine SYS6006 targets some major Omicron variants and its booster dose showed…
BioNTech initiates clinical trial of mRNA-based malaria vaccine candidate
The phase-I trial is expected to enroll 60 volunteers in the United States (US) with no history of malaria to evaluate the vaccine…
Japan’s Meiji Holdings says drug unit started late-stage trial for COVID vaccine
Meiji Seika Pharma had started the late-stage trial among 780 subjects in Japan, with the test period running from November to…
Pfizer sees $10-$15 billion in annual mRNA vaccine revenue by 2030
The company provided potential revenue details from vaccines across its portfolio, including its already-approved COVID-19 vaccine…
DCGI approves India’s maiden mRNA vaccine against COVID-19
The vaccine by Geneva Biopharma will be sold under the brand name Gemcovac-19
NIH launches clinical trial of three mRNA HIV vaccines
Phase-I study is amongst the first to examine mRNA technology for HIV
Moderna to develop mRNA-based shingles vaccine
The success of COVID-19 vaccines based on messenger RNA (mRNA) technology from Moderna and rival Pfizer has prompted efforts to…